Post-IPO Equity Pharmaceutical Companies

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Kanabo is creating a new standard in the medical cannabis industry by building an ecosystem.

Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

Australis Capital is a pharmaceutical public company that develops and helps grow the cannabis industry to meet the growing market demand.

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

Phathom Pharmaceuticals is a biopharmaceutical company.

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.